Teva Sues Perrigo, Catalent to Can Their ANDA Plans for Asthma Drug

Drug Industry Daily
A A
Teva is suing Perrigo and Catalent Pharma Solutions to stop the companies’ plans to market and develop generic versions of its asthma drug ProAir HFA before two key patents pop.

To View This Article:

Login

Subscribe To Drug Industry Daily